The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist

Kazuhiro Shimizu, Takuo Iiduka, Shuji Sato, Hajime Kiyokawa, Takahiro Nakagami, Hiroshi Mikamo, Masayo Kawazoe, Mao Takahashi, Mahito Noro Department of Internal Medicine, Toho University Sakura Medical Center, Sakura City, Chiba, Japan Background: For the management of venous thromboembolism (VTE...

Full description

Bibliographic Details
Main Authors: Shimizu K, Iiduka T, Sato S, Kiyokawa H, Nakagami T, Mikamo H, Kawazoe M, Takahashi M, Noro M
Format: Article
Language:English
Published: Dove Medical Press 2018-02-01
Series:Therapeutics and Clinical Risk Management
Subjects:
venous thromboembolism
deep vein thrombosis
anticoagulant therapy
quantitative ultrasound thrombosis score
FXa inhibitors
Online Access:https://www.dovepress.com/the-clinical-course-of-symptomatic-deep-vein-thrombosis-after-3-months-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/the-clinical-course-of-symptomatic-deep-vein-thrombosis-after-3-months-peer-reviewed-article-TCRM

Similar Items